Klotho Neurosciences, Inc.
KLTO
$1.54
$0.042.67%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
6/18/2025
-
GuruFocus
6/18/2025
-
GuruFocus
6/18/2025
-
GuruFocus
6/18/2025
-
The Fly
6/18/2025
-
PR Newswire
6/16/2025
-
TipRanks Financial Blog
6/16/2025
-
GuruFocus
6/16/2025
-
GuruFocus
6/16/2025
-
PR Newswire
6/13/2025
-
TipRanks Financial Blog
6/12/2025
-
MarketBeat
6/10/2025
-
MarketBeat
6/10/2025
-
MarketBeat
6/10/2025
-
Stocktwits News Feed
6/9/2025
-
MarketBeat
6/9/2025
-
MarketBeat
6/9/2025
-
MarketBeat
6/9/2025
-
TipRanks Financial Blog
6/9/2025
-
MarketBeat
6/9/2025
-
PR Newswire
6/2/2025
-
TipRanks Financial Blog
5/17/2025
-
Ticker Report
1/31/2025
-
Ticker Report
1/8/2025
-
GuruFocus
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 15, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Jun 16 and 20 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
833 931 6330
Address
13576 Walnut Street
Omaha, NE 68144
Omaha, NE 68144
Country
Year Founded
--
Business Description
Sector
Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates consist of KLTO-101 for the...
more